TABLE 1

Normal Biodistribution Studies in BALB/c Mice at 10, 30, 60, and 120 Minutes After Intravenous Injection of 18F-FPTP

Organ10 min30 min60 min120 min
Blood0.39 ± 0.080.18 ± 0.020.04 ± 0.010.04 ± 0.02
Heart20.57 ± 2.8123.82 ± 3.2321.23 ± 3.6023.04 ± 3.68
Lung4.96 ± 1.044.91 ± 1.052.96 ± 0.632.98 ± 0.27
Liver4.81 ± 1.404.76 ± 1.063.05 ± 0.922.15 ± 0.46
Spleen1.82 ± 0.531.79 ± 0.301.42 ± 0.441.09 ± 0.20
Stomach4.51 ± 1.384.69 ± 1.264.34 ± 1.243.99 ± 0.91
Intestine8.45 ± 1.9211.33 ± 2.709.25 ± 5.653.69 ± 2.05
Kidney25.65 ± 6.6614.25 ± 4.3611.68 ± 3.736.35 ± 2.59
Pancreas7.33 ± 1.358.06 ± 3.737.46 ± 1.405.53 ± 1.29
Normal muscle6.18 ± 2.226.62 ± 1.366.16 ± 1.786.06 ± 0.93
Bone1.89 ± 0.631.79 ± 0.621.70 ± 0.711.57 ± 0.68
Heart to liver4.46 ± 0.955.16 ± 0.987.25 ± 1.4410.72 ± 2.17
Heart to lung4.21 ± 0.474.94 ± 0.677.28 ± 1.077.72 ± 1.09
Heart to muscle3.73 ± 1.513.69 ± 0.743.55 ± 0.483.80 ± 0.82
Heart to blood54.10 ± 13.91133.49 ± 10.45523.34 ± 31.41553.01 ± 23.59
  • Data are expressed as %ID/g (n = 24). Myocardial uptake of 18F-FPTP was >20 %ID/g at 10 min after radiotracer injection. Heart-to-blood ratio of 18F-FPTP was >54, and heart-to-lung and heart-to-liver ratios were >4 and >4, respectively, at 10 min.